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SUMMARY
It has been proposed that two amino acid substitu-
tions in the transcription factor FOXP2 have been
positively selected during human evolution due to
effects on aspects of speech and language. Here,
we introduce these substitutions into the endoge-
nous Foxp2 gene of mice. Although these mice are
generally healthy, they have qualitatively different
ultrasonic vocalizations, decreased exploratory
behavior and decreased dopamine concentrations
in the brain suggesting that the humanized Foxp2
allele affects basal ganglia. In the striatum, a part of
the basal ganglia affected in humans with a speech
deficit due to a nonfunctional FOXP2 allele, we find
that medium spiny neurons have increased dendrite
lengths and increased synaptic plasticity. Since
mice carrying one nonfunctional Foxp2 allele show
opposite effects, this suggests that alterations in cor-
tico-basal ganglia circuits might have been important
for the evolution of speech and language in humans.
For a video summary of this article, see the Paper-
Flick file available with the online Supplemental Data.
INTRODUCTION
Identification of the genomic differences that underlie the pheno-
typic traits that set humans apart from their closest relatives
among the primates is important from an evolutionary, medical
and a cultural perspective (Enard and Pa¨a¨bo, 2004; Varki et al.,
2008). The sequencing of human, chimpanzee and rhesus
macaque genomes has accomplished the first step toward this
goal by cataloguing the 20 million genomic changes that
occurred on the human evolutionary lineage (Mikkelsen et al.,
2005). The current challenge, therefore, is not to identify
human-specific genomic features, but to distinguish the small
number of features that may have phenotypic consequences
from the vast majority of functionally neutral features. Since
crosses between humans and chimpanzees are not possible,
this can only be achieved by the analysis of additional informa-
tion such as the extent of evolutionary conservation among
primates, population variation among humans and disease asso-
ciations. Examples of such work include the identification of
a noncoding RNA gene that evolved rapidly on the human
lineage (Pollard et al., 2006), evidence for positive selection in
genes involved in primary microcephaly (Gilbert et al., 2005)
and evidence for positive selection in FOXP2 (Enard et al.,
2002; Zhang et al., 2002), a gene involved in speech and
language disorders (Lai et al., 2001; MacDermot et al., 2005).
Once such candidate features are identified, the next challenge
is to test whether they are indeed involved in any human-specific
phenotype. This is obviously a difficult task since genetic
manipulations of humans or chimpanzees are impossible and
the mouse is the only mammal into which genetic changes can
currently be efficiently introduced and their effects tested.
Although human disease mutations have been successfully962 Cell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc.modeled in the mouse (Cox and Brown, 2003) it is unclear
whether the supposedly slight phenotypic effects of human-
specific evolutionary changes can be modeled and recognized
in the mouse. Here we establish a mouse model and study the
functional consequences of evolutionary changes that affected
the transcription factor FOXP2 in humans.
Individuals that are heterozygous for FOXP2 alleles that carry
a missense mutation (R553H) affecting the forkhead DNA
binding domain of the protein, a nonsense mutation (R328X) or
disruptions of the gene by a chromosomal rearrangement suffer
from a developmental impairment especially affecting speech
and language (Lai et al., 2001; MacDermot et al., 2005; Var-
gha-Khadem et al., 2005). Analyses of the evolution of the
FOXP2 gene in primates identified two amino acid substitutions
(T303N, N325S), which became fixed on the human lineage after
its separation from the chimpanzee and which appear to have
been subject to positive selection (Enard et al., 2002; Zhang
et al., 2002). It has been hypothesized that these substitutions
underwent selection due to effects on some aspects of speech
and language (Enard et al., 2002; Zhang et al., 2002). Conve-
niently, FoxP2 in chimpanzees differs from Foxp2 in mice by
only one conservative amino acid substitution (D80E). Thus,
the wild-type mouse Foxp2 protein can be regarded as a model
for the ancestral version of the human FOXP2 protein and
compared to a partly ‘‘humanized’’ version in which the two
amino acid replacements have been introduced (Figure 1A).
RESULTS
Generation of Mice
The two nucleotide substitutions that occurred during human
evolution are both located in exon seven of the FOXP2 gene.
We introduced these two substitutions into the orthologous
exon of the mouse Foxp2 gene by homologous recombination
in embryonic stem (ES) cells derived from C57BL/6 mice
(Figure 1A and Figure S1 available with this article online). This
‘‘humanized’’ mouse allele (Foxp2hum) segregates in Mendelian
ratios (chi-square = 1.44, n = 636, p = 0.49) and Foxp2hum/hum
mice seem healthy, and are as fertile and as long-lived (data
not shown) as their wild-type littermates. This is in stark contrast
to mice homozygous for knock-out or nonfunctional mutant
alleles of Foxp2, which die 3–4 weeks after birth (French et al.,
2007; Fujita et al., 2008; Groszer et al., 2008; Shu et al., 2005).
Thus, the Foxp2hum allele is generally functional in mice.
We also crossed mice carrying Foxp2hum to mice ubiquitously
expressing Cre recombinase to generate a Foxp2ko allele in
which exon 7 is deleted (Figure 1B). This is expected to lead to
a truncated Foxp2 protein of 291 amino acids. We did not
analyze homozygous Foxp2ko/ko mice in any detail, but similar
to mice homozygous for an allele with a nonsense mutation
(S321X) in exon 7 (Groszer et al., 2008) they show reduced
Foxp2 mRNA levels and an absence of truncated Foxp2 protein
(Figure S2). This is likely due to a combination of nonsense-medi-
ated RNA decay (Groszer et al., 2008) and instability of truncated
proteins (Vernes et al., 2006). Heterozygous Foxp2wt/ko mice
show intermediate levels of Foxp2 protein (Figure S2) and can
thus be used to assess the consequences of reduced Foxp2
expression. This may be useful since effects caused by the
AB
Figure 1. Introduction of Human FOXP2 Substitutions into Mice
(A) Since the human and chimpanzee lineages diverged, human FOXP2 changed at two amino acid positions (T303N and N325S). Only one other amino acid
substitution separates humans and chimpanzees from mice (D80E). We generated a Foxp2 knock-in allele (Foxp2hum) of the endogenous mouse Foxp2 gene.
Foxp2hum carries the substitutions T302N and N324S which are orthologous to the human substitutions. Its neomycin resistance cassette is flanked by FRT sites
(green arrows) and exon 7 which carries the substitutions is flanked by loxP sites (blue arrows). Equal amounts of Foxp2 protein are detected in embryonic brains
of mice homozygous for Foxp2hum (h/h) and homozygous for the Foxp2 wild-type allele (+/+). See Figure S1 for further details.
(B) A nonfunctional Foxp2ko allele was generated from the Foxp2hum allele using Cre-mediated recombination in order to model the R328X nonsense mutation
(MacDermot et al., 2005) and the R553H missense mutation (Lai et al., 2001) in humans with speech impairment. This leads to an absence of Foxp2 protein in
Foxp2ko/ko embryos and intermediate levels of Foxp2 in Foxp2ko/wt mice (Figure S2).Foxp2hum allele may conceivably be due to impaired Foxp2 func-
tion in the mouse background that could be functionally similar to
a reduced amount of protein. Furthermore, since humans that
are heterozygous for nonfunctional FOXP2 variants exhibit
speech and language deficits (Lai et al., 2001; MacDermot
et al., 2005), these mice may model FOXP2 effects that lead to
speech and language impairments in humans (Groszer et al.,
2008). Hence, these mice can be used to assess whether pheno-
typic changes in Foxp2hum/hum mice might be related to the
evolution of speech and language.
A Comprehensive Phenotypic Screen
Foxp2 is expressed in the brain (Campbell et al., 2009; Ferland
et al., 2003; Lai et al., 2003; Takahashi et al., 2003) as well as
in a wide variety of other tissues (Lai et al., 2001; Shu et al.,
2005, 2007). For example, it has been proposed to play a role
in combination with Foxp1 during the development of the lung
and the esophagus (Shu et al., 2007). Thus, the Foxp2hum allele
may have effects in multiple organs. To investigate which phys-
iological systems might be affected by the human amino acid
substitutions we analyzed a total of 60 animals, 15 of each homo-
zygous genotype and sex, derived from 17 litters of heterozy-
gous parents in a large standardized phenotypic screen at the
German Mouse Clinic (Gailus-Durner et al., 2005) (see Supple-
mental Data S2 for a detailed description) that assesses morpho-
logical traits (Fuchs et al., 2000), hearing, vision, bone
morphology and density (Fuchs et al., 2006), various clinical-
chemical parameters and hematological parameters, includingleukocyte subpopulations and classes of immunoglobulins,
metabolism, lung function, blood pressure and heart function.
We also studied 24 neurological parameters (Schneider et al.,
2006) including forepaw grip strength and nociception as well
as motor coordination and motor learning, which were assessed
on an accelerating rotarod over 3 consecutive days. Sensori-
motor behavior was examined by the acoustic startle response
and the prepulse inhibition of the startle response. Locomotor
activity, exploration, novel object recognition and frequency of
contact with group members was assessed using the modified
hole board (Ohl et al., 2001). Finally, 31 tissues were analyzed
histologically. Many known sex differences were identified in
these tests. For the vast majority of tests, no significant Foxp2hum
effects were found (Table S1). There were, however, two excep-
tions: First, several measurements indicated a reduced explor-
atory behavior on the modified hole board (see below) and this
was also evident from a reduced forward locomotor activity in
the neurology screen (ANOVA, n = 60, p < 0.05). Second, in elec-
trocardiograms Foxp2hum/hum mice had lower R-wave ampli-
tudes (ANOVA, n = 39, p < 0.01). To test if these results are
robust, we analyzed heart function and behavior on the modified
hole board in a second batch of 60 mice. These animals were
derived from a different ES cell clone and had the Neomycin
cassette (Figure 1A) removed by FLPe recombination between
FRT-sites flanking the Neomycin cassette (Supplemental Data
S1). No effect of the Foxp2hum allele on R-amplitude (ANOVA,
n = 59, p = 0.7) was seen in these animals suggesting that
Foxp2hum has little or no effect on heart function. However, weCell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc. 963
again found several measurements indicating reduced explor-
atory behavior of Foxp2hum/hum mice (Table S2). Importantly,
we found no significant interaction between genotype and batch
for any parameter, suggesting that the effect of Foxp2hum is inde-
pendent of the ES cell clone and the presence of the Neomycin
cassette (Table S3).
On the modified hole board (Figure S3),Foxp2hum/hummice from
both batches traveled significantly shorter distances (ANOVA, n =
109, p < 0.001) at a significantly lower mean velocity (p < 0.001),
made fewer turns (p < 0.01), crossed fewer lines (p < 0.01), entered
the hole board less often (p < 0.01), explored fewer holes (p < 0.01)
and stayed closer to the wall (p < 0.05) than their wild-type litter-
mates (Figure S3 and Table S5). Since Foxp2hum/hum mice perform
as well as their wild-type littermates on the rotarod and show no
other signs of motoric impairments (Table S1), their altered
behavior can be interpreted as a slightly reduced exploratory
activity in a novel environment. The effect also seems to be rela-
tively specific for exploratory behavior since we did not find any
behavioral effects in a light-dark box or in an elevated plus maze,
two tests assessing anxiety-related behavior (Table S2).
To put these results into perspective, we compared 25 mice
heterozygous for the Foxp2ko allele to 23 wild-type littermates
in the primary phenotypic screen (Table S4). We found that
Foxp2wt/ko mice reacted less to a clicking sound (p < 0.001),
show slightly impaired motor learning on the rotarod (less
improvement over trials at day 1: p < 0.01), had a higher amount
of fat mass (p < 0.05) and a lower amount of lean mass (p < 0.05),
consumed more food (p < 0.05), assimilated more energy (p <
0.05), had a higher respiratory rate during activity and at rest
(p < 0.05), a lower pulse rate (p < 0.05), slightly higher plasma
Ferritin (p < 0.05) and lower plasma inorganic phosphorus (p <
0.05) concentrations and higher proportions of CD62L CD8a+
and CD4+ and CD8+ T cells (p < 0.05). Although we did not repli-
cate these results in a second batch of animals, these results
indicate that reduced expression of Foxp2 has several subtle,
but significant effects on multiple organs other than the brain.
Interestingly, although measures of forward locomotor activity
of Foxp2wt/ko mice were reduced on the modified hole board,
other parameters, such as a longer exploration of an unfamiliar
object (ANOVA, n = 48, p < 0.05), suggest a slightly increased
exploratory behavior of Foxp2wt/ko mice (Table S4). Indeed,
several parameters differ significantly between Foxp2wt/ko mice
and Foxp2hum/hum mice, indicating increased exploratory be-
havior in Foxp2wt/ko mice and decreased exploratory behavior
in Foxp2hum/hum mice (Figure 2 and Table S5).
In summary, we find a reproducible and specific effect of the
Foxp2hum allele on mouse exploratory behavior, but no signifi-
cant effect on almost 300 other measurements assessing
a variety of physiological systems. This indicates that the
Foxp2hum allele affects predominantly the brain. Furthermore,
this does not seem to be a simple loss-of-function effect of the
Foxp2hum allele in the mouse since Foxp2wt/ko mice show
different and partly opposite effects.
Foxp2hum Reduces Dopamine Levels
Given that the phenotypic screen indicated that the Foxp2hum
allele affects the brain rather than other organ systems, we
further investigated the effects of the humanized Foxp2 in this964 Cell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc.organ. We first compared the brains of at least one Foxp2wt/wt
and one Foxp2hum/hum mouse at embryonic day 16.5 (E16.5),
postnatal day (P) 1, P10, P20 and 3 months with respect to gross
anatomy and Foxp2 protein expression and found no differences
(Figures S4–S6). Expression patterns agreed well with published
results, i.e., expression and nuclear localization of Foxp2 was
observed in a subset of postmitotic neurons in the striatum,
the thalamus, cortical layer VI, the cerebellum (Purkinje cells),
and several other areas (Ferland et al., 2003; Lai et al., 2003;
Takahashi et al., 2003).
Next, we analyzed the tissue concentrations of four major
neurotransmitters (glutamate, serotonin, dopamine and GABA)
in five brain regions (frontal cortex, cerebellum, caudate-puta-
men, nucleus accumbens and globus pallidus) from 10 male
Foxp2hum/hum mice and 10 male Foxp2wt/wt littermates. We found
a reduction in dopamine concentrations in all regions (repeated-
measure ANOVA, p < 0.001) in Foxp2hum/hum mice but no effects
for any of the other neurotransmitters (Table S6). When com-
paring neurotransmitter levels between 10 male Foxp2wt/ko and
10 male Foxp2wt/wt littermates in the same way, we find an
increase in dopamine levels in all regions (repeated-measure
ANOVA, p < 0.05; Figure 3) as well as an increase in serotonin
levels especially in the nucleus accumbens (Table S6).
Hence, similar to the patterns observed for exploratory
behavior, Foxp2hum/hum and Foxp2wt/ko mice show opposite
effects on their dopamine levels. These effects could be causally
linked since increasing extracellular dopamine levels pharmaco-
logically or genetically tends to increase exploratory behavior
and vice versa (David et al., 2005; Viggiano et al., 2003).
However, tissue levels of dopamine largely reflect the storage
pool of dopamine (Gainetdinov et al., 1998). Further studies are
Figure 2. Different Exploratory Behavior of Foxp2hum/hum and
Foxp2wt/ko Mice on the Modified Hole Board
All parameters that differ significantly between Foxp2wt/ko (striped bars) and
Foxp2hum/hum mice (solid bars) are shown (see Table S5 and Supplemental
Data S3 for details). Means (±SEM) are normalized to wild-type levels of the
respective littermates (dashed line). Asterisks represent significance levels of
0.05 (*) and 0.01 (**).
needed to clarify effects on extracellular dopamine levels in
Foxp2hum/hum and Foxp2wt/ko mice as well as the underlying
mechanism. However, since Foxp2 is not expressed in dopami-
nergic neurons (Wijchers et al., 2006) any mechanism is probably
indirect. In this regard, it is interesting that Foxp2 is expressed in
many medium spiny neurons (Ferland et al., 2003; Lai et al.,
2003; Scharff and Haesler, 2005; Takahashi et al., 2003), which
are the major targets of dopaminergic neurons, and make up
over 90% of neurons in the striatum. For several reasons they
may be of relevance with respect to the role of Foxp2 in speech
and language development. First, the striatum is structurally and
functionally affected in patients heterozygous for the FOXP2-
R553H substitution that impairs speech and language (Liegeois
et al., 2003; Vargha-Khadem et al., 1998; Watkins et al.,
2002b). Second, medium spiny neurons show abnormal function
in mice that are heterozygous for a substitution equivalent to this
human mutation (Foxp2-R552H) (Groszer et al., 2008). Third, in
birds, a knock-down of FoxP2 in a striatal nucleus (A, area X)
impairs vocal imitation (Haesler et al., 2007). Therefore, we
decided to further investigate the effects of Foxp2hum on medium
spiny neurons.
Foxp2hum Increases Dendritic Length
We isolated striatal neural precursor cells from Foxp2hum/hum
embryos and their Foxp2wt/wt littermates and compared their
proliferation and differentiation in vitro. The two genotypes did
not differ significantly in cell growth or survival rate during proli-
feration (Supplemental Data S6). However, 7 days after differen-
tiation, Foxp2hum/hum cells positive for the neural marker TUBB3
Figure 3. Brain Dopamine Concentrations in Foxp2hum/hum and
Foxp2wt/ko Mice
Mean postmortem dopamine concentrations (±SEM) relative to wild-type litter-
mates (dashed line) are given for Foxp2hum/hum (solid bars) and Foxp2wt/ko
(striped bars) mice in different brain regions. Asterisks above columns indicate
a significant difference to wild-type levels (Student’s t test), and asterisks above
brackets indicate a significant difference betweenFoxp2hum/humandFoxp2wt/ko
mice (see also Table S6).had neurites, i.e., outgrowths from the cell body that may repre-
sent axons as well as dendrites, that were on average 80%
longer than in Foxp2wt/wt cells (Mann-Whitney U, p < 0.01;
Figure 4A). In contrast, the size of the cell bodies was not signi-
ficantly different between genotypes (data not shown).
In order to test the in vivo relevance of this finding, we stained
adult brains using the Golgi-Cox method and measured the total
dendrite length of three medium spiny neurons each in nine
Foxp2wt/wt, six Foxp2hum/hum and six Foxp2wt/ko mice. We found
that Foxp2hum/hum mice had dendritic trees that were on average
22% longer than Foxp2wt/wt mice (Mann-Whitney U, p < 0.05)
and Foxp2wt/ko mice (p < 0.05; Figure 4B). Foxp2wt/ko mice
tended to have neurons with shorter dendrites when compared
to their Foxp2wt/wt littermates, but this difference was not signi-
ficant (Mann-Whitney U, p = 0.145). Thus, Foxp2hum increases
the length of the dendritic trees of medium spiny neurons in vitro
as well as in vivo.
Foxp2hum Increases Long-Term Synaptic Depression
Medium spiny neurons integrate glutamatergic input from the
cortex and dopaminergic input from the midbrain and generate
output that contributes to the control and selection of appro-
priate behaviors via cortico-basal ganglia circuits (Graybiel,
2008) and the strength of corticostriatal synapses are important
for acquiring and altering behaviors (Berretta et al., 2008). In
order to investigate whether Foxp2hum influences plasticity of
corticostriatal synapses, we recorded membrane potentials of
medium spiny neurons in acute tissue slices and studied the
long-term depression (LTD) of their depolarization after high-
frequency stimulation of cortical fibers. Current-voltage relation-
ships and resting membrane potentials did not differ between
Foxp2hum/hum and Foxp2wt/wt neurons (Figure S7), indicating
that they do not differ grossly in their physiology. However,
LTD was almost twice as strong in Foxp2hum/hum neurons
compared to Foxp2wt/wt neurons (repeated-measures ANOVA,
n = 17, p < 0.05; Figure 5). In stark contrast, it has been reported
(Groszer et al., 2008) that LTD in mice heterozygous for the
R552H mutation, which corresponds to the R553H mutation
implicated in human speech and language deficits, is almost
absent in striatal neurons. Thus, whereas Foxp2hum increases
synaptic plasticity in medium spiny neurons, a nonfunctional
Foxp2 allele has the opposite effect.
Foxp2hum and Striatal Gene Expression
Genome-wide gene expression patterns were analyzed in stria-
tal biopsies from embryos (E16.5), young animals (P15-P21) and
adults (3 month old) in a total of 30 Foxp2hum/hum mice and their
23 Foxp2wt/wt littermates using high-density oligonucleotide
arrays (see Supplemental Data S8 for details). The significance
of results was assessed by generating 1,000 data sets where
genotype labels were randomly permutated. This is a conserva-
tive approach that is robust against violations of analysis
assumptions, for example the assumption that the expression
levels of genes are independent of each other (Tusher et al.,
2001). At a threshold of p < 0.001 (F-test after correcting for
batch, age and sex effects), the expression of 34 genes differs
between Foxp2hum/hum and Foxp2wt/wt mice in the observed data
(Figure S8A), while on average four genes differ at this thresholdCell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc. 965
in the permutations (i.e., a false discovery rate of 12%). Among the
1,000 permutated data sets, 36 show 34 or more genes to differ
(i.e., permutation test p < 0.05). In the promoters of the genes
that are higher expressed in Foxp2hum/hum mice, Foxp2 binding
motifs (Wang et al., 2003) are enriched (permutation test p <
0.05; e.g., the motif TATTTAT occurs on average 2.6 times in
such genes and 1.8 times in other genes), indicating that some
of these genes may be primary targets of the humanized version
of Foxp2. In conclusion, the analysis shows that Foxp2hum has
a significant effect on gene expression patterns in the striatum. It
should be noted, however, that although many animals were
analyzed, the expression of relatively few genes were found to
be significantly affected by Foxp2hum and the expression of those
that are affected differ by no more than 30% from wild-type levels
(Figure S8A). Two evolutionary amino acid substitutions in a tran-
scription factor are not necessarily expected to cause major
changes in gene expression and it is certainly possible that the
subtle expression changes observed is sufficient to cause the
phenotypic effects seen in the animals. However, we can obvi-
ously not exclude that the Foxp2hum allele causes more
pronounced changes in expression patterns at other time points
during striatal development, or in other parts of the brain.
We also analyzed gene expression in striatal biopsies from 12
Foxp2wt/ko and their 6 Foxp2wt/wt littermates (P15–P21). Foxp2
expression in the former mice is reduced to 68% of that in their
wild-type littermates in agreement with what is seen in embry-
onic brains (Figure S2). When Foxp2wt/ko and Foxp2hum/hum
mice (P15-P21) are compared to their wild-type littermates,
gene expression tends to be affected in opposite directions
(Spearman rank correlation of effect sizes across genes =
A
B
Figure 4. Foxp2hum Increases the Length of
Dendritic Trees
(A) Foxp2hum/hum and Foxp2wt/wt striatal neurons stained
for the neuronal marker beta–III-tubulin (green) after
7 days of differentiation. Plotted are averages (±SEM) of
three individuals for each of which the total neurite length
of five neurons was measured. Asterisks indicate a signifi-
cant difference (Mann-Whitney U, p < 0.01) between the
15 neurons of each genotype.
(B) Golgi-Cox staining and representative drawings of
medium spiny neurons in vivo. Plotted are averages
(±SEM) of six (nine for Foxp2wt/wt) individuals for each
genotype of which the total dendritic tree of three neurons
has been measured. Asterisks indicate a significant differ-
ence (Mann-Whitney U, p < 0.05) between the neurons of
each genotype. Scale bars represent 25 mm.
0.18; permutation test p = 0.2). Interestingly,
among the 106 genes with higher expression in
Foxp2wt/ko and lower expression in Foxp2hum/hum,
24 are known to be preferentially expressed in
medium spiny neurons expressing the D1 dopa-
mine receptor (Heiman et al., 2008), whereas
only one would be expected by chance (permu-
tation test p < 0.01; Figure S8B). In contrast, no
such effect is seen for genes preferentially
expressed in medium spiny neurons expressing
the D2 dopamine receptor (Supplemental Data
S8). Since Foxp2 itself is preferentially expressed in the former
cells (Heiman et al., 2008), this suggests that among the two
major known subtypes of medium spiny neurons that differ
e.g., in their axonal projections and their electrophysiological
properties (Kreitzer and Malenka, 2008), Foxp2 primarily affects
D1 positive medium spiny neurons .
Foxp2hum Alters Vocalization
Finally, to assess whether Foxp2hum impacts vocalization, we re-
corded ultrasonic vocalizations emitted by pups when placed
outside the nest (Ehret, 2005) at day P4, P7, P10, and P13
from 32 Foxp2hum/hum mice and 39 Foxp2wt/wt littermates. Using
a semi-automated procedure to extract single calls and a general
linear model (GLM) with the variables postnatal day, genotype,
sex, litter and weight we found no significant differences in the
number of calls emitted per minute or in the duration of intervals
between calls (GLM, n = 71, p > 0.4; Figure S9A). To analyze the
structure of calls (Figure 6A), we assigned them to one of four
categories: (1) calls shorter than 50 ms with no frequency jumps;
(2) calls longer than 50 ms with no frequency jumps; (3) calls with
frequency jumps; and (4) remaining sounds, which were not
analyzed (see Figure S9B for spectrographic displays of call
types). The first call type, which was the most frequent, showed
no difference between the two genotypes with regard to the
number of calls, the duration of calls and five other parameters
(Table S7). However, Foxp2hum/hum animals, they had a signifi-
cantly lower start peak frequency (p < 0.001), and lower mean
(p < 0.01), minimum (p < 0.01) and maximum (p < 0.001) peak
frequencies (Figure 6B). In addition, the slope of the calls
declined less in frequency (p < 0.01, Figure 6B) and were locally
966 Cell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc.
less modulated (p < 0.01). Analyses using a second batch of
animals that originated from a different ES cell clone, confirmed
these findings except for the parameter local modulation (Table
S8 and Supplemental Data S9). Further, similar nonsignificant
tendencies were observed for calls longer than 50 ms (data not
shown), whereas calls with frequency jumps lasted longer
(ANOVA, n = 149, p < 0.05), had longer gaps (p < 0.05) and
started (p < 0.01) and ended (p < 0.05) with higher peak frequen-
cies in Foxp2hum/hum mice than in their wild-type littermates
(Table S9 and Figure S9C).
Mice homozygous for nonfunctional Foxp2 alleles produce
much fewer isolation calls than their wild-type littermates (Fujita
et al., 2008; Groszer et al., 2008; Shu et al., 2005), but given that
these animals suffer from severe developmental deficits and die
around 3 weeks after birth, this finding may not represent
specific effects of Foxp2 on mouse vocalizations (Groszer
et al., 2008). It has been suggested that mouse pups heterozy-
gous for nonfunctional Foxp2 alleles have mild developmental
delays and produce fewer ultrasonic calls (Fujita et al., 2008;
Shu et al., 2005), but these observations could not be verified
in another study (Groszer et al., 2008). Notably, studies of mouse
pups with nonfunctional Foxp2 alleles have not identified differ-
ences in the structural properties of calls (Groszer et al., 2008;
Shu et al., 2005). Hence, the Foxp2hum allele affects ultrasonic
isolation calls of mice subtly but specifically and does so in
a way different from nonfunctional Foxp2 alleles.
DISCUSSION
A Mouse Model for Human Evolution?
To the best of our knowledge, our analysis of Foxp2hum mice
represents the first investigation of amino acid substitutions of
Figure 5. Foxp2hum Increases Long-Term Depression in Medium
Spiny Neurons
Mean ± SEM amplitudes normalized to baseline levels at time 0 are shown
from Foxp2hum/hum (n = 8) and Foxp2wt/wt neurons (n = 9). Following 20 min
baseline stimulation, three high-frequency tetani were applied (100 Hz, 3 s)
separated by 30 s. Asterisks indicate significantly different means (Student’s
t test) between Foxp2hum/hum (open squares) and Foxp2wt/wt (filled squares)
neurons.potential relevance for human evolution in an animal model.
This raises the question whether such genetic changes can
be reasonably modeled in a mouse. One concern is that pheno-
typic effects elicited in the mouse could simply represent an
inability of the human gene product to function in the mouse
background. A complete inability of the Foxp2hum allele to
function in the mouse would be equivalent to a knockout of
Foxp2. Since Foxp2hum/hum mice are fertile and healthy, whereas
mice homozygous for nonfunctional Foxp2 alleles die within
3–4 weeks after birth (French et al., 2007; Fujita et al., 2008;
Groszer et al., 2008; Shu et al., 2005), Foxp2hum certainly func-
tions in the mouse, at least with respect to major effects with
obvious phenotypic consequences. Furthermore, when the
effects seen in Foxp2hum/hum mice are compared to mice hetero-
zygous for nonfunctional Foxp2 alleles they are either not
observed in the latter mice (e.g., altered vocalization) or show
opposite effects to those seen in such mice (e.g., exploratory
behavior, dopamine levels, long-term depression). Hence, it
seems unlikely that the effects seen in Foxp2hum/hum mice are
caused by a simple reduction in biological activity of Foxp2hum
in the mouse background.
Given that Foxp2hum/hum mice are generally healthy, how can
any specific phenotypic effects be found if they exist? Since
FOXP2 is expressed in many organs (Lai et al., 2001; Shu
et al., 2001) and Foxp2hum could have effects in any number of
these, it is crucial to perform a comprehensive phenotypic
screen where the functions of many organ systems are assessed
in order not to bias results to organs or behaviors which may
a priori be deemed interesting. An analysis of many organ
systems is also crucial in order to assess the extent to which
effects detected are specific to an organ system or may be
secondary, especially if they are subtle as may be expected for
evolutionary innovations that occurred over short time scales.
Thus, we analyzed almost 300 different phenotypic parameters
in the mice. None of them produced any evidence for effects
of the Foxp2hum allele in any organ system except the central
nervous system. This suggests that the two amino acid substitu-
tions that occurred on the human evolutionary lineage specifi-
cally affected the brain in the mouse. We therefore focused the
further analyses on this organ.
Of special interest is obviously if any of the effects detected
in the Foxp2hum/hum mice might have something to do with any
aspect of speech and language in humans. Since humans
heterozygous for a nonfunctional FOXP2 allele show speech
and language impairments (Lai et al., 2001; MacDermot et al.,
2005; Vargha-Khadem et al., 2005), a comparison with
Foxp2wt/ko mice may be helpful as they may recapitulate
aspects of speech and language impairment. Thus, traits
affected in opposite directions in Foxp2wt/ko and Foxp2hum/hum
mice are of potential interest as candidates for being involved
in aspects of speech and language evolution. We find that
exploratory behavior, dopamine levels, striatal gene expression
patterns and striatal synaptic plasticity are all affected in oppo-
site directions in Foxp2hum/hum and Foxp2wt/ko mice respec-
tively in mice heterozygous for a nonfunctional Foxp2 allele
(Groszer et al., 2008). As argued in detail below, some of these
effects could model aspects relevant for speech and language
in humans.Cell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc. 967
A B Figure 6. Foxp2hum Affects the Structure of
Pup Isolation Calls
(A) Examples of acoustic parameters analyzed
illustrated for typical call.
(B) Plots of acoustic parameters differing between
genotypes. Measurements are averaged across
days and individuals (±SEM). The peak frequency
(PF) refers to the frequency with the maximum
amplitude in each analyzed time window of
0.21 ms. Asterisks indicate significant differences
between genotypes (**: < 0.01; ***: < 0.001).Relevance of Ultrasonic Vocalization
The fact that Foxp2hum influences ultrasonic vocalization of pups
in a specific and reproducible way is of obvious interest.
However, it is important to note that this influence is subtle and
within the range of normal variation among mice. A relevant
question is also to what extent mouse vocalization can be
compared to human speech. All terrestrial mammals produce
their vocalizations by an air stream from the lungs that passes
the larynx and generates sounds. In most animals, oscillations
of the vocal folds and/or specific structures of the vocal folds
generate the sound through oscillations (Fitch, 2000; Ham-
merschmidt and Fischer, 2008; Lieberman, 2006). Ultrasonic
vocalizations in rodents are also produced by the larynx (Rob-
erts, 1975a) but they are thought to derive from an aerodynamic
whistle rather than vibrations of vocal cords (Roberts, 1975b).
Nevertheless, the basic neurological and muscular systems
necessary for vocalizations probably overlap to a large degree
in mice and humans (Hammerschmidt and Fischer, 2008; Ju¨r-
gens, 2002). Indeed, some neural circuits important for vocaliza-
tion are even conserved in fish (Bass et al., 2008). Hence, the fact
that Foxp2hum influences the structure of isolation calls in the
mouse, especially since this effect is not accompanied by phys-
iological effects outside the brain, supports the hypothesis that
the two amino acid substitutions that occurred during human
evolution affect aspects of speech and/or language.
However, we currently cannot exclude that very subtle
changes in lung function or larynx morphology that could be irrel-
evant for speech and language evolution can be responsible for
the effects on call structures, despite the fact that we find no indi-
cation that e.g., lung function is influenced by Foxp2hum in adults.
Furthermore, it is important to remember that vocalizations of
mice as well as most other terrestrial mammals are considered
to be innate. Humans share innate vocalizations like grunts,
cries, and screams with other animals, but in addition humans
have an unmatched ability to learn vocalizations (Egnor and
Hauser, 2004; Hammerschmidt and Fischer, 2008). The acquisi-
tion and extensions of neural circuits making voluntary control of
vocalizations possible is thought to be a hallmark in the evolution
of human speech (Ju¨rgens, 2002; Krubitzer, 2007). Since little is
known about the neurological and anatomical basis of mouse
vocalizations, it is an open question if some neural circuits
homologous to the ones making voluntary vocalizations possible
in humans would be affected in the Foxp2hum/hum mice. Hence,
more studies will be needed to clarify to what extent mouse
vocalizations can model aspects of human speech evolution.968 Cell 137, 961–971, May 29, 2009 ª2009 Elsevier Inc.As argued below, it will be especially important to clarify any
functional relationship to Foxp2hum-dependent effects on cor-
tico-basal ganglia circuits.
Cortico-Basal Ganglia Circuits and Speech
and Language
The fact that Foxp2hum affects dopamine levels, dendrite
morphology, gene expression and synaptic plasticity of medium
spiny neurons indicates that it impacts cortico-basal ganglia
circuits where medium spiny neurons in the striatum receive
contextual information from the cortex and reward signals from
dopaminergic neurons and send integrated signals to brain
stem structures and the cortex (Graybiel, 2008). Several lines
of evidence indicate that cortico-basal ganglia circuits could
be relevant for speech and language (Lieberman, 2002; Lieber-
man, 2006; Ullman, 2001). For example, reduced dopamine
release in the striatum is positively correlated with speed and
accuracy of phonological processing (Tettamanti et al., 2005),
activation of a part of the striatum plays a crucial role in lexical-
semantic control (Crinion et al., 2006), and patients with Hunting-
ton’s disease show - dependent on the striatal subregions
affected - impairments in the retrieval of lexical information and
the application of combinatorial rules (Teichmann et al., 2008).
Furthermore, cortico-basal ganglia circuits and their dopami-
nergic modulations are crucial for song learning in birds, which
is thought to resemble aspects of vocal learning in humans
(Hara et al., 2007; Jarvis, 2004). This is supported by the recent
finding that when FoxP2 expression is knocked down in basal
ganglia of songbirds, vocal imitation is impaired (Haesler et al.,
2007). Furthermore, individuals heterozygous for a nonfunctional
FOXP2 allele show structural effects and functional impairments
in the striatum (Vargha-Khadem et al., 2005; Vargha-Khadem
et al., 1998) supporting a role for FOXP2 in cortico-basal ganglia
circuits with respect to speech and language.
In conclusion, it is possible that the effects on cortico-basal
ganglia circuits seen in the Foxp2hum/hum mice model aspects
of speech and language evolution in humans. It will now be
important to further explore the mechanistic basis of these
effects and their possible relationship to phenotypic differences
between humans and apes. Currently, one can only speculate
about the role these effects may have played during human
evolution. However, since patients that carry one nonfunctional
FOXP2 allele show impairments in the timing and sequencing
of orofacial movements (Alcock et al., 2000; Watkins et al.,
2002a), one possibility is that the amino acid substitutions in
FOXP2 contributed to an increased fine-tuning of motor control
necessary for articulation, i.e., the unique human capacity to
learn and coordinate the muscle movements in lungs, larynx,
tongue and lips that are necessary for speech (Lieberman,
2006). We are confident that concerted studies of mice, humans
and other primates will eventually clarify if this is the case.
EXPERIMENTAL PROCEDURES
Generation of Mice
Mice carrying the Foxp2hum allele were generated by Ozgene (Bentley,
Australia) from two C57BL/6 ES cell clones that had integrated the vector via
homologous recombination. Whereas the first line (clone 5H10) was used for
initial analyses, the second one (clone 5H11) was used for testing the repro-
ducibility of the results from the first line. To this end, some mice were gener-
ated that carried a Foxp2hum allele in which the Neomycin resistance cassette
had been removed by crossings with a FLPe deleter strain. Mice carrying the
Foxp2ko allele were generated by crossing chimeric mice (clone 5H11) to a B6
Cre deleter strain (Ozgene, Bentley, Australia). and subsequent crosses to re-
move the Cre transgene. All animal work was performed in accordance with
governmental and institutional ethical guidelines.
Immunohistochemistry
Mice were transcardially perfused with 4% paraformaldehyde in PBS and
brains were either paraffin embedded (E16.5) or cryopreserved (P1, P10,
P20, and adults). Sections were immunostained with antibodies against
FOXP2 (HPA000382 Atlas Antibodies, Stockholm, Sweden or ab16046,
Abcam, Cambridge, UK).
Neurotransmitter Measurements
Biopsies were taken from frozen brain slices of 10 male Foxp2hum/hum mice and
10 male Foxp2wt/wt littermates as well as from 10 male Foxp2wt/ko mice and 10
male Foxp2wt/wt littermates. Neurotransmitter levels were measured by high-
performance liquid chromatography and normalized to the protein content
of the sample to determine their concentrations. We used an ANOVA with brain
regions treated as repeated-measures and genotype as factor to determine
significant differences between genotypes separately for each strain and
neurotransmitter. Differences between Foxp2wt/ko mice and Foxp2hum/hum
mice were identified by a significant interaction between strain and genotype
in a combined analysis, again using brain regions as repeated-measures.
Neuronal Cell Culture
Striatal neural precursor cells were dissected from E14-old embryos,
expanded for 4 weeks as three-dimensional (neurosphere) cultures during
which proliferation and cell survival was measured. Differentiation was
induced via replacement of expansion media by media containing 1% FCS
and 5 mM forskoline on precoated poly L-lysine coverslips. After 7 days cells
were stained with DAPI and antisera against the neural marker TUBB3. For
three cultures per genotype, we measured neurite length of five neurons each.
Golgi Staining
Brains were isolated from six 12-week-oldFoxp2hum/hummice and six wild-type
littermates (derived from the 5H11 line in which the Neomycin cassette had
been removed) and six 12-week-old Foxp2wt/ko mice and three wild-type litter
mates. Golgi-Cox staining was performed using the FD Rapid GolgiStain kit (FD
NeuroTechnologies, Ellicott City, MD, USA) according to the manufacturer’s
protocol. Stained slices were sectioned at a thickness of 200 mm using a cryo-
microtome (Microm Thermo Scientific, Walldorf, Germany). Medium spiny
neurons were identified by their morphology using a Axiovert 200 microscope
equipped with a xyz motorized stage and their dendrites were traced using
Mercator software (Explora Nova, La Rochelle, France).
Electrophysiology
Acute brain slices were prepared from the brains of 15- to 27-day-old
Foxp2hum/hum mice and their wild-type littermates (all derived from the 5H11
line in which the Neomycin cassette had been removed) and medium spinyneurons in the striatum were recorded at a holding potential of 70 mV. Excit-
atory medium spiny neuron afferents were stimulated to yield largest EPSC
amplitudes without eliciting an action potential or inducing direct stimulation.
Continuous stimulation was performed at a frequency of 0.5 Hz. Following
20 min. of baseline stimulation, we applied 3 tetani of 3 s duration and
a frequency of 100 Hz separated by 30 s. LTD was then measured for
30 min. Data points were calculated every 30 s by averaging the last 15 EPSCs.
LTD data was analyzed using a repeated-measures ANOVA with genotype as
fixed factor.
Gene Expression Analysis
Total RNA from striatal biopsies of 13 Foxp2hum/hum embryos (E16.5) and 12
Foxp2wt/wt littermates (prepared in two separate batches), 11 Foxp2hum/hum
mice (P15, P18, P21) and 6 Foxp2wt/wt littermates, 12 Foxp2wt/ko mice (P15,
P18, P21) and 6 Foxp2wt/wt littermates as well as 6 Foxp2hum/hum mice (3 month
old) and 6 Foxp2wt/wt littermates was labeled and hybridized to Affymetrix
Mouse Genome 430 2.0 arrays. Expression levels were calculated using Bio-
conductor (Gentleman et al., 2004) and custom CDF files (Dai et al., 2005).
Genotype-dependent effects were assessed after correcting for batch, age
and sex effects using multiple regression. Using Cohen’s D estimate of effect
size, we correlated genotype-dependent effects with functional annotations
(Pru¨fer et al., 2007), putative FOXP2 targets in a human neuroblastoma cell
line (Vernes et al., 2007), the number of putative Foxp2 binding motifs (Wang
et al., 2003) 5 kbp upstream and 2 kbp downstream of the transcription start
site and genes differently expressed in D1 and D2 positive striatal cells (Hei-
man et al., 2008). The significance of the genotype-dependent effects was in
each case assessed against at least 300 permutations of genotype labels.
All primary expression data are available at the NCBI GEO database (acces-
sion number GSE13588).
Vocalization
For each recording at P4, P7, P10, and P13, a pup was selected randomly,
placed on a cotton pad in a plastic beaker, weighed and recorded for 2 min
(3 min for P13) in a soundproof plexiglas box. Calls were counted using the
AVISOFT Recorder 2.97 (Avisoft Bioacoustics, Berlin). For the analysis of
call structure, we visually inspected all recordings to ensure that the auto-
mated sampling routine selected only calls of mouse pups and calculated
spectrograms. We submitted the resulting spectrograms to a custom software
to extract a set of acoustic parameters (Table S7). To eliminate an overrepre-
sentation of subjects with high vocal activity, we randomly selected a
maximum of 10 calls per subject and recording day. The mean values per
subject and recording day were analyzed using a general linear mixed model
(SPSS 13.0), with day (P4, P7, P10, and P13) as within-subject factor, weight
as covariate and genotype, sex, and litter as fixed between-subject factors.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
tables, nine figures, and a video summary and can be found with this article on-
line at http://www.cell.com/supplemental/S0092-8674(09)00378-X.
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